F. Lalouette et al., PRESENCE OF SPECIFIC PLATELET-ACTIVATING-FACTOR BINDING-SITES IN NEUROBLASTOMA N1E-115 CELLS, Neuroscience letters, 186(2-3), 1995, pp. 173-176
In this study we reported evidence for the existence of specific bindi
ng sites for platelet-activating factor (PAF) in neuroblastoma N1E-115
cells. The specific [H-3]PAF binding reached a steady state level wit
hin 60 min at 25 degrees C. Scatchard analysis of the specific [H-3]PA
F binding revealed the presence of two apparent populations of binding
sites. The high-affinity binding site possessed a K-d1 of 2.5+/-0.6 p
M and B-max1 = 57.3+/-20.0 fmol/mg protein. The low-affinity binding s
ite possessed a K-d2 = 3.2+/-1.0 nM and B-max2 = 4.4+/-2.1 pmol/mg pro
tein, Furthermore, the total [H-3]PAF binding was partially displaced
by unlabelled PAF, PAF antagonists BN 52021 and BN 50730 in a dose-dep
endent manner. This study confirms the presence of specific PAF recept
ors in neuronal cells.